Working… Menu

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02944201
Recruitment Status : Active, not recruiting
First Posted : October 25, 2016
Last Update Posted : February 21, 2021
Albert Einstein College of Medicine
Information provided by (Responsible Party):
Benjamin Gartrell, Montefiore Medical Center

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2021